Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status

AIM/HYPOTHESIS: The glucose-lowering drug metformin has been shown to activate hepatic AMP-activated protein kinase (AMPK), a master kinase regulating cellular energy homeostasis. However, the underlying mechanisms remain controversial and have never been investigated in primary human hepatocytes. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephenne, X., Foretz, M., Taleux, N., van der Zon, G. C., Sokal, E., Hue, L., Viollet, B., Guigas, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210354/
https://www.ncbi.nlm.nih.gov/pubmed/21947382
http://dx.doi.org/10.1007/s00125-011-2311-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210354/
https://www.ncbi.nlm.nih.gov/pubmed/21947382
http://dx.doi.org/10.1007/s00125-011-2311-5

Ejemplares similares